These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 22722778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A.
    BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 31; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 4. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
    Bomback AS, Tumlin JA, Baranski J, Bourdeau JE, Besarab A, Appel AS, Radhakrishnan J, Appel GB.
    Drug Des Devel Ther; 2011 Mar 14; 5():147-53. PubMed ID: 21448451
    [Abstract] [Full Text] [Related]

  • 5. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
    Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA.
    Clin J Am Soc Nephrol; 2013 Dec 14; 8(12):2072-81. PubMed ID: 24009220
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
    Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G.
    Kidney Int; 2000 Oct 14; 58(4):1732-41. PubMed ID: 11012907
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun 14; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Leveraging melanocortin pathways to treat glomerular diseases.
    Gong R.
    Adv Chronic Kidney Dis; 2014 Mar 14; 21(2):134-51. PubMed ID: 24602463
    [Abstract] [Full Text] [Related]

  • 14. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG.
    Clin Nephrol; 1995 Sep 14; 44(3):156-62. PubMed ID: 8556831
    [Abstract] [Full Text] [Related]

  • 15. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 14; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 16. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P, Schneider A, Grabensee B, Plum J.
    Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
    [Abstract] [Full Text] [Related]

  • 17. Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective.
    AlSahow A, Al-Muhaiteeb A, Nawar H, AlHelal B, AlYousef A, Abdallah E, AbuShall A, Elmekawi S, Meshal B, AlQallaf A, AlRajab H.
    Med Princ Pract; 2022 Oct 05; 31(2):133-141. PubMed ID: 35021170
    [Abstract] [Full Text] [Related]

  • 18. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W.
    Clin Sci (Lond); 1992 Jun 05; 82(6):641-50. PubMed ID: 1320544
    [Abstract] [Full Text] [Related]

  • 19. Partial remission of resistant nephrotic syndrome after oral galactose therapy.
    Kopač M, Meglič A, Rus RR.
    Ther Apher Dial; 2011 Jun 05; 15(3):269-72. PubMed ID: 21624074
    [Abstract] [Full Text] [Related]

  • 20. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH).
    Bomback AS, Radhakrishnan J.
    Discov Med; 2011 Aug 05; 12(63):91-6. PubMed ID: 21878186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.